Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
Eutilex ((주)유틸렉스) is a biotech company developing anti-tumor T-cell therapy and antibody therapeutics based on its proprietary immunotherapy technology.
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
Rapperswil-Jona, CH HQ
Cambridge, US HQ
Total funding raised
Total funding raisedN/A
Total funding raised$ 18.9m
Total funding raised$ 50m